Emerging nano-derived therapy for the treatment of dementia: a comprehensive review
- PMID: 40268841
- DOI: 10.1007/s13346-025-01863-3
Abstract
Dementia includes a variety of neurodegenerative diseases that affect and target the brain’s fundamental cognitive functions. It is undoubtedly one of the diseases that affects people globally. The ameliorating the disease is still not known; the symptoms, however, can be prevented to an extent. Dementia encompasses Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Lewy body dementia, mixed dementia, and various other diseases. The aggregation of β-amyloid protein plaques and the formation of neurofibrillary tangles have been concluded as the foremost cause for the onset of the disease.
As the cases climb, new neuroprotective methods are being developed in the form of new drug delivery systems that provide targeted delivery. Herbal drugs like Ashwagandha, Brahmi, and Cannabis have shown satisfactory results by not only treating the symptoms but have also been shown to reduce and ameliorate the formation of amyloid plaque formation. This article explores the intricate possibilities of drug delivery and the absolute use of herbal drugs to target neurodegenerative diseases. The various possibilities of nanotechnology currently available with new emerging techniques are also discussed.
Keywords: Alzheimer’s disease, Dementia, Herbal drugs, Huntington’s disease, Nanotechnology, Neurodegenerative diseases, Novel therapies, Parkinsonism
© 2025. Controlled Release Society.
Conflict of interest statement
Declaration. Ethics approval and consent to participate: Not applicable. Consent for publication: The author declares that they have provided their consent to publish this manuscript. Competing interests: The authors declare that they have no known competing financial or other interests that could have appeared to influence the work reported in this paper.
References
-
- Arnulf I, Leu S, Oudiette D. Abnormal sleep and sleepiness in Parkinson’s disease.
-
- Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold spring harbor perspectives in medicine. 2012;2(8):a006239. https://doi.org/10.1101/cshperspect.a006239
-
- Lampropoulos IC, Malli F, Sinani O, Gourgoulianis KI, Xiromerisiou G. Worldwide trends in mortality related to Parkinson’s disease in the period of 1994–2019: Analysis of vital registration data from the WHO Mortality Database. Frontiers in neurology. 2022;13:956440. https://doi.org/10.3389/fneur.2022.956440
Freedom Wares Takeaway:
This research highlights how herbal medicines, including Cannabis, Ashwagandha, and Brahmi, may reduce amyloid plaque buildup in neurodegenerative diseases like Alzheimer’s. Combined with targeted delivery through nanotechnology, these plant-based strategies offer promising neuroprotective benefits. As cases of dementia continue to rise, natural therapies paired with scientific advances are carving new paths in care and prevention.

